Results 91 to 100 of about 2,105 (188)

Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice

open access: yesVirulence, 2018
Background: Cystic fibrosis (CF) lung infection is a complex condition where opportunistic pathogens and defective immune system cooperate in developing a constant cycle of infection and inflammation.
Angela Sandri   +8 more
doaj   +1 more source

Can metal complexes serve as hypoxia activated prodrugs? Investigations of a Co(III) complex of the MMP inhibitor marimastat

open access: yes, 2003
For many years proof that the hypoxic nature of malignant tumours can be used to selectively target anticancer drugs has been sought. Several classes of potential redox activated anticancer drugs have been developed to take advantage of the reducing ...
Cullinane, C. M.   +5 more
core   +1 more source

Marimastat reversed hepatic steatosis and improved surrogate markers for insulin sensitivity in diet-induced obese mice as well as in ob/ob animals.

open access: yes, 2013
Mean hepatic fat fraction as measured by MR spectroscopy was decreased following Marimastat treatment (A). Marimastat treatment resulted in a decrease of plasma alanine aminotransferase levels (B), indicating decreased hepatic injury.
Hau D. Le (343378)   +5 more
core   +1 more source

An in vitro model that can distinguish between effects on angiogenesis and on established vasculature: Actions of TNP-470, marimastat and the tubulin-binding agent Ang-510

open access: yes, 2010
In anti-cancer therapy, current investigations explore the possibility of two different strategies to target tumor vasculature: one aims at interfering with angiogenesis, the process involving the outgrowth of new blood vessels from pre-existing vessels,
Bloys, H.   +9 more
core   +1 more source

p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification

open access: yesJournal of Translational Medicine, 2018
Background Malignant pleural mesothelioma (MPM) is an orphan disease that is difficult to treat using traditional chemotherapy, an approach which has been effective in other types of cancer.
Kun Tian   +9 more
doaj   +1 more source

Incorporation of Bulky and Cationic Cyclam-Triazole Moieties into Marimastat Can Generate Potent MMP Inhibitory Activity without Inducing Cytotoxicity.

open access: yes, 2013
The synthesis and matrix metalloproteinase (MMP) inhibitory activity of a cyclam-marimastat conjugate and its metal complexes are described. The conjugate, synthesized with a copper(I)-catalyzed Huisgen 1,3-dipolar cycloaddition ("click" reaction ...
Yu, M   +8 more
core   +1 more source

Effects of Marimastat on serum adipokine levels, fatty acid export from the liver and TACE activity.

open access: yes, 2013
C57BL/6 animals were fed a high fat diet for 9 weeks, followed by two weeks of treatment with either Marimastat (MAR) or vehicle (VEH) control. Ob/ob animals were fed a normal fat diet and received 4 weeks of MAR or VEH control.
Hau D. Le (343378)   +5 more
core   +1 more source

Inside a Metastatic Fracture: Molecular Bases and New Potential Therapeutic Targets

open access: yesCancer Medicine
Introduction Bone metastases and pathological fractures significantly impact the prognosis and quality of life in cancer patients. However, clinical and radiological features alone have been shown to fail to predict skeletal related events of a bone ...
Alessandro Bruschi   +10 more
doaj   +1 more source

Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a model of aneurysm disease

open access: yesJournal of British Surgery, 1999
Abstract Background Abdominal aortic aneurysms are characterized by degradation of the extracellular matrix, with a reduction in the elastin concentration of the arterial media. These changes have been linked to increased levels of endogenous metalloproteinases (MMPs) within the aorta, particularly ...
G D, Treharne   +5 more
openaire   +2 more sources

Effects of AB0041 on rat joints.

open access: yes, 2015
(A) Assessment of AB0041 (50 mg/kg, twice daily) and marimastat (5.5–7 mg/kg/day) in an MSS model: Mean total disease scores (+/- SD) of rats treated with AB0041, marimastat, or vehicle are shown.
Christopher O’Sullivan (456385)   +16 more
core   +1 more source

Home - About - Disclaimer - Privacy